Benapenem

DRUG3 trials

Sponsors

Sihuan Pharmaceutical Holdings Group Ltd.

Conditions

Complicated Urinary Tract Infection Including Acute PyelonephritisComplicated Urinary Tract Infection; CutiHealthy Subject

Phase 1

Single-dose PK Study of Benapenem In Healthy Subjects

CompletedNCT03588156

Sihuan Pharmaceutical Holdings Group Ltd.Healthy Subject

Start: 2015-03-11End: 2015-09-17Updated: 2018-07-17

Pharmacokinetics of Benapenem in Subjects With Renal Impairment

CompletedNCT04476407

Sihuan Pharmaceutical Holdings Group Ltd.Complicated Urinary Tract Infection; Cuti

Start: 2019-06-15End: 2019-10-21Updated: 2020-07-20

Phase 2

A Study to Assess Efficacy and Safety Intravenous Benapenem in Patients With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)

CompletedNCT04505683

Sihuan Pharmaceutical Holdings Group Ltd.Complicated Urinary Tract Infection Including Acute Pyelonephritis

Start: 2018-12-13End: 2020-05-08Updated: 2020-08-10

Related Papers

A First-in-Human Safety, Tolerability, and Pharmacokinetics Study of Benapenem in Healthy Chinese Volunteers.

2019-02-2610 citations